Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Prospective Trial of Vaccine Responses Against Pneumococcus and Influenza in Adult Cancer Patients 65 Years of Age and Older

Phase 2

Completed

Conditions: Breast Cancer
Prostate Cancer
Lung Cancer

Interventions: Biological: inactivated influenza vaccine and the 23- valent pneumococcal vaccine
Biological: inactivated influenza vaccine and the PPV23 vaccine (Pneumovax)

First Posted Date: 2008-08-26

Last Posted Date: 2015-11-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 126

Registration Number: NCT00741039

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung Cancer

Phase 2

Completed

Conditions: Lung Cancer

Interventions: Drug: Temozolomide

First Posted Date: 2008-08-25

Last Posted Date: 2016-08-01

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 92

Registration Number: NCT00740636

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
🇺🇸
Memoral Sloan Kettering Cancer Center, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan-Kettering Cancer Center at Commack, Commack, New York, United States

and more 2 locations

Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies.

Phase 2

Completed

Conditions: Chronic Myelogenous Leukemia
Leukemia
Myelodysplastic Syndrome
Hodgkins Lymphoma
Non-Hodgkins Lymphoma

Interventions: Drug: fludarabine, cyclophosphamide, thiotepa, radiation therapy, unrelated donor umbilical cord blood graft

First Posted Date: 2008-08-21

Last Posted Date: 2022-12-08

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 86

Registration Number: NCT00739141

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma

Phase 2

Completed

Conditions: Esophageal Cancer
Gastric Cancer

Interventions: Drug: epirubicin, cisplatin, capecitabine, bevacizumab, docetaxel and irinotecan

First Posted Date: 2008-08-19

Last Posted Date: 2016-02-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 22

Registration Number: NCT00737438

Locations: 🇺🇸
Memoral Sloan Kettering Cancer Center@Phelps, Sleepy Hollow, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, Rockville Centre, New York, United States

Weekly Nanoparticle Albumin-Bound Paclitaxel (Abraxane) + Weekly Cetuximab + Radiation Therapy (IMRT, Intensity-Modulated Radiation Therapy) in Patients With Stage III-IVB Head and Neck Squamous Cell Carcinoma (HNSCC)

Phase 1

Completed

Conditions: HEAD & NECK Cancer

Interventions: Other: Cetuximab, IMRT, Albumin-bound paclitaxel (Abraxane®)

First Posted Date: 2008-08-18

Last Posted Date: 2016-08-10

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 25

Registration Number: NCT00736619

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memoral Sloan Kettering Cancer Center@Phelps, Sleepy Hollow, New York, United States
🇺🇸
Memorial Sloan Kettering at Mercy Medical Center, Rockville Centre, New York, United States

Awareness and Attitudes Regarding Prenatal and Preimplantation Genetic Diagnosis for Inherited Breast/Ovarian Cancer Risk

Completed

Conditions: Breast Cancer
Ovarian Cancer

Interventions: Behavioral: questionnaire, interview

First Posted Date: 2008-08-14

Last Posted Date: 2010-10-11

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 34

Registration Number: NCT00735150

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Multiple Respiration-Correlated Cone Beam Computed Tomography (CT) Scans to Reduce Target Positioning Errors in Radiotherapy Treatment of Thoracic Cancer

Phase 1

Completed

Conditions: Esophageal Cancer
Lung Cancer

Interventions: Procedure: cone-beam CT

First Posted Date: 2008-07-25

Last Posted Date: 2013-01-24

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 16

Registration Number: NCT00722605

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Drug: capecitabine, lapatinib

First Posted Date: 2008-07-24

Last Posted Date: 2017-08-15

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 24

Registration Number: NCT00721630

Locations: 🇺🇸
Memorial Sloan-Kettering at Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital Center, Sleepy Hollow, New York, United States

and more 2 locations

Physical Activity Intervention for Lung Cancer Survivors

Completed

Conditions: Survivor
Lung Cancer

Interventions: Behavioral: interview and wait list
Behavioral: interview and physical activity

First Posted Date: 2008-07-18

Last Posted Date: 2023-06-07

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 52

Registration Number: NCT00717795

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Upper Extremity Lymphatic Mapping for Breast Cancer Patients

Not Applicable

Completed

Conditions: Axillary Lymph Node Dissection
Breast Cancer

Interventions: Radiation: isosulfan blue dye

First Posted Date: 2008-07-18

Last Posted Date: 2015-11-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 13

Registration Number: NCT00717886

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy